AI assistant
TISSUE REGENIX GROUP PLC — Board/Management Information 2015
Feb 26, 2015
7973_rns_2015-02-26_852d2b34-7998-4fef-bc90-23e44215f20c.html
Board/Management Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 9636F
Tissue Regenix Group PLC
26 February 2015
Tissue Regenix plc
26 February 2015
Tissue Regenix Group plc
("Tissue Regenix" or the "Company")
Resignation of Dr Alison Fielding as Non-Executive Director
Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix" or "the Group"), the international regenerative medical devices company, announces that Dr Alison Fielding has stepped down as a Non-Executive Director of the Company with immediate effect.
In accordance with the Company's strategy to evolve the composition of the Board, the search for an independent Non-Executive Director is well underway.
John Samuel, Non-Executive Chairman of Tissue Regenix, commented:
"On behalf of everyone at Tissue Regenix I would like to thank Alison for her valuable contribution to the current Board over the last 2 years and for her involvement with the Company over the past decade. We wish her all the very best."
Enquiries:
Tissue Regenix Group plc Tel: 01904 435 176
Antony Odell, Chief Executive Officer
Ian Jefferson, Chief Financial Officer
Tulchan Communications Tel: 020 7353 4200
Tom Buchanan / Victoria Huxster
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCSEEFSMFISELE